The main cons are that Retatrutide is not yet approved for clinical use, gastrointestinal side effects are common during the first 8 to 12 weeks, a new safety signal called dysesthesia emerged in Phase 3, long-term data beyond 68 weeks is still limited, and weight tends to return after discontinuing treatment
As per the suggestions from the experts, this injection should be avoided by individuals having allergies to vitamins of any kind, patients with cardiovascular problems, breastfeeding mothers and pregnant mothers
Parents may also choose to use assisted reproductive techniques to decrease the chance that their future children would have CTD
Tanuja Mulaparthi 546 days ago First time at Shumailas Clinic for an IV drip and Im SO impressed
Trahair LG, Horowitz M, Hausken T, Feinle-Bisset C, Rayner CK, Jones KL